Ubiquitin Specific Peptidase 39 (USP39) Peptid
USP39
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN985993
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Ubiquitin Specific Peptidase 39 (USP39) Peptid (ABIN985993)
Target
USP39
(Ubiquitin Specific Peptidase 39 (USP39))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-USP39 antibody (Catalog #: ARP38825_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- USP39 (Ubiquitin Specific Peptidase 39 (USP39))
-
Hintergrund
-
USP39 may play a role in mRNA splicing. It is unsure if the protein really exhibits hydrolase activity. It could be a competitor of ubiquitin C-terminal hydrolases
Alias Symbols: 65K, SAD1, CGI-21, HSPC332, SNRNP65
Protein Interaction Partner: ACVR1,C17orf79,CD2BP2,DDX23,DDX24,DHX38,EFTUD2,GAR1,MEPCE,NAA38,NOC3L,PA2G4,PRPF3,PRPF31,PRPF4,PRPF4B,PRPF6,PRPF8,RG9MTD1,RNMTL1,RPL22L1,RRP8,SART1,SART3,SNRNP200,SNRNP27,SNRNP40,TP53,TSR2,TXNL4A,USP12,ZRANB2
Protein Size: 565 -
Molekulargewicht
- 65 kDa
-
Gen-ID
- 10713
-
NCBI Accession
- NM_006590, NP_006581
-
UniProt
- Q53GS9
Target
-
Sie sind hier:
